ArticleFrontiers in oncology2022

Metabolomics profiling in prediction of chemo-immunotherapy efficiency in advanced non-small cell lung cancer.

Lihong Mei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.